SCHEMBL16707017

SCHEMBL16707017

CCOC(=O)c1nc(C)sc1NC(C)=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.60
ALDH1A1 P00352 7/20 0.52
HPGD P15428 1/20 0.52
GAA P10253 1/20 0.50
ALOX15 P16050 1/20 0.46
CYP1A2 P05177 3/20 0.45
CYP2C9 P11712 2/20 0.45
KDM4E B2RXH2 2/20 0.45
CYP3A4 P08684 1/20 0.45
NPC1 O15118 2/20 0.45
MAPT P10636 5/20 0.44
KMT2A Q03164 4/20 0.44
MEN1 O00255 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 3/20 0.44
RAB9A P51151 2/20 0.44
ALOX12 P18054 1/20 0.44
STAT1 P42224 1/20 0.44
CYP2C19 P33261 1/20 0.44
PRKCZ Q05513 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24554041 0.88 TSHR (0.47) TSHRALDH1A1HPGDGAAALOX15
SCHEMBL1194098 0.86 MAPK1 (0.55) TSHRALDH1A1HPGDGAACYP1A2
SCHEMBL13263371 0.84 ALDH1A1 (0.47) TSHRALDH1A1HPGDGAACYP1A2
SCHEMBL22658880 0.83 TSHR (0.44) TSHRALDH1A1HPGDGAACYP1A2
SCHEMBL29517486 0.83 ALDH1A1 (0.46) TSHRALDH1A1HPGDGAACYP1A2
SCHEMBL2826113 0.81 TSHR (0.41) TSHRALDH1A1HPGDGAACYP1A2
SCHEMBL18394517 0.80 ALDH1A1 (0.44) TSHRALDH1A1HPGDGAACYP1A2
SCHEMBL13224737 0.79 SMN1; SMN2 (0.56) TSHRALDH1A1HPGDGAACYP1A2
SCHEMBL31518545 0.79 HPGD (0.46) TSHRALDH1A1HPGDGAACYP1A2
SCHEMBL1564192 0.78 TSHR (0.39) TSHRALDH1A1HPGDGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102637-B2 Bicyclic thiazole compounds CARNA BIOSCIENCES, INC. (JP) 2015-08-11 US disclosed
US-20150133656-A1 NOVEL BICYCLIC THIAZOLE COMPOUNDS CARNA BIOSCIENCES INC. (JP) 2015-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133656-A1 NOVEL BICYCLIC THIAZOLE COMPOUNDS TNIK, TNNI3K, TNK1 TSHR 2869/4885ALDH1A1 3946/4885HPGD 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.